Sitemap
Search
Contact
Professional´s Home
Management with Pritor / Kinzal
Overview
Mode of action
Efficacy
Prescribing Information
Resource Centre
News & Events
Upcoming Events 2010
New indication in CVD prevention
ESH 2010, Oslo
ESC 2009, Barcelona
ESH 2009, Milan
4th Standalone Symposium, Lisbon
3rd Standalone Symposium, Athens
EASD 2008, Rome
ESC 2008, Munich
ESH 2008, Berlin
ICMA 2007, Brussels
2nd Standalone Symposium, Rome
ESC 2007, Vienna
ESH 2007, Milan
1st Standalone Symposium, Malta
Cardiometabolism Online
Press Centre
Bayer Links
Bayer Global
Bayer HealthCare
Bayer Schering Pharma
Adalat
Aspirin Cardio
Glucobay
ICMAedu
Cardiometabolism
General Conditions of Use
Privacy Statement
Imprint
Copyright ©
Bayer Schering Pharma AG
Sitemap
Professional´s Home
Management with Pritor / Kinzal
Overview
Mode of action
Dual Activity
Additional metabolic benefits
Efficacy
Strong blood pressure control
Efficacy maintained over 24 hours with a single dose
Prevention of cardiovascular disease
Better tolerability and treatment compliance
Investigated cardiovascular and renal protection
Prescribing Information
Resource Centre
News & Events
Upcoming Events 2010
New indication in CVD prevention
ESH 2010, Oslo
ESC 2009, Barcelona
ESH 2009, Milan
4th Standalone Symposium, Lisbon
3rd Standalone Symposium, Athens
EASD 2008, Rome
ESC 2008, Munich
ESH 2008, Berlin
ICMA 2007, Brussels
2nd Standalone Symposium, Rome
ESC 2007, Vienna
ESH 2007, Milan
1st Standalone Symposium, Malta
Cardiometabolism Online
Press Centre
Patient's Home
Quiz
Pagetools
Printer friendly version
Bookmark this page
Recommend this page
http://www.kinzal.com/scripts/pages/en/professional/sitemap.php
Copyright © Bayer Schering Pharma AG
